|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
New York, June 21, 2016-- Moody's Investors Service assigned a B1 Corporate Family Rating and B1-PD Probability of Default Rating to Arbor Pharmaceuticals, LLC. Moody's also assigned a B1 rating to the ...
Xenoport (XNPT) could be good choice for investors as it is seeing decent short-term momentum and positive earnings estimate revisions.
A generous deal from a specialty pharma company made May a month to remember for Xenoport investors.